1. Methylation of the first exon in the erythropoietin receptor gene does not correlate with its mRNA and protein level in cancer cells
   Barbora Fecková et al, 2019, BMC Genetics CrossRef
2. Recombinant Human erythropoietin reduces viability of MCF-7 breast cancer cells from 3D culture without caspase activation
   Hareth Y. ShujaaEdin et al, 2021, Saudi Journal of Biological Sciences CrossRef
3. Pan-Cancer Analysis Based on EPOR Expression With Potential Value in Prognosis and Tumor Immunity in 33 Tumors
   Yajing Zhang et al, 2022, Frontiers in Oncology CrossRef
4. Recombinant human erythropoietin accelerated the proliferation of non‐small cell lung cancer cell lines and reduced the expression of VEGF, HIF‐1α, and PD‐L1 under a simulated hypoxic environment in vitro
   Yajing Zhang et al, 2022, Chronic Diseases and Translational Medicine CrossRef
5. Differentially Expressed Genes Induced by Erythropoietin Receptor Overexpression in Rat Mammary Adenocarcinoma RAMA 37-28 Cells
   Zuzana Tóthová et al, 2023, International Journal of Molecular Sciences CrossRef
6. Erythropoietin receptor is a risk factor for prognosis: A potential biomarker in lung adenocarcinoma
   Yajing Zhang et al, 2023, Pathology - Research and Practice CrossRef